In addition, histological analysis of S100A2 and HMGB1 reflects the severity of drug eruption [62,111], however, they could not reflect the specificity of drug eruption, because they are increased in other inflammatory skin diseases, such as atopic dermatitis and psoriasis. This evidence concerns the gene S100A2 and psoriasis.